Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| ARCH Venture Management, LLC | 6.29M | $136.0M | 11.76% | -- | 2026-06-30 |
| GENERAL ATLANTIC, L.P. | 6.10M | $132.0M | 11.40% | -- | 2026-06-30 |
| Sofinnova Investments, Inc. | 3.56M | $77.0M | 6.66% | -- | 2026-06-30 |
| GOLDMAN SACHS GROUP INC | 2.18M | $47.0M | 4.07% | -- | 2026-06-30 |
| TRV GP VI, LLC | 2.06M | $44.0M | 3.85% | -- | 2026-06-30 |
| CANADA PENSION PLAN INVESTMENT BOARD | 1.98M | $42.0M | 3.69% | -- | 2026-06-30 |
| JPMORGAN CHASE & CO | 1.82M | $40.0M | 3.39% | -- | 2026-06-30 |
| Foresite Capital Management VI LLC | 1.78M | $38.0M | 3.32% | -- | 2026-06-30 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.31M | $28.0M | 2.44% | -- | 2026-06-30 |
| FMR LLC | 1.19M | $25.0M | 2.21% | -- | 2026-06-30 |
